Bioventix (LON:BVXP) Announces Earnings Results

Bioventix (LON:BVXP) issued its quarterly earnings data on Monday. The biotechnology company reported GBX 72.27 ($0.93) earnings per share for the quarter, Digital Look Earnings reports. Bioventix had a net margin of 59.51% and a return on equity of 69.09%.

Bioventix Price Performance

Bioventix stock traded down GBX 328 ($4.24) during mid-day trading on Monday, reaching GBX 2,422 ($31.32). 21,114 shares of the company were exchanged, compared to its average volume of 5,670. The company has a fifty day simple moving average of GBX 2,908.58 and a 200-day simple moving average of GBX 3,367.22. The firm has a market cap of £126.82 million, a PE ratio of 15.66 and a beta of 0.35. Bioventix has a 12 month low of GBX 2,400 ($31.03) and a 12 month high of GBX 4,800 ($62.06).

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.